Actinic Prurigo

Skinmed. 2015 Aug 1;13(4):287-95; quiz 296. eCollection 2015 Jul-Aug.

Abstract

Actinic prurigo is an idiopathic photodermatosis that affects the skin, as well as the labial and conjunctival mucosa in indigenous and mestizo populations of Latin America. It starts predominantly in childhood, has a chronic course, and is exacerbated with solar exposure. Little is known of its pathophysiology, including the known mechanisms of the participation of HLA-DR4 and an abnormal immunologic response with increase of T CD4+ lymphocytes. The presence of IgE, eosinophils, and mast cells suggests that it is a hypersensitivity reaction (likely type IVa or b). The diagnosis is clinical, and the presence of lymphoid follicles in the mucosal histopathologic study of mucosa is pathognomonic. The best available treatment to date is thalidomide, despite its secondary effects.

Publication types

  • Review

MeSH terms

  • Dermatologic Agents / therapeutic use*
  • HLA-DR4 Antigen / genetics
  • Humans
  • Photosensitivity Disorders / diagnosis
  • Photosensitivity Disorders / drug therapy
  • Photosensitivity Disorders / physiopathology*
  • Skin Diseases, Genetic / diagnosis
  • Skin Diseases, Genetic / drug therapy
  • Skin Diseases, Genetic / physiopathology*
  • Sunlight / adverse effects
  • Thalidomide / adverse effects
  • Thalidomide / therapeutic use*

Substances

  • Dermatologic Agents
  • HLA-DR4 Antigen
  • Thalidomide

Supplementary concepts

  • Actinic Prurigo